KAZIA THERAPEUTICS LTD Logo

KAZIA THERAPEUTICS LTD

Oncology-focused biotech developing targeted therapies for cancers with high unmet needs.

KZIA | US

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
THREE INTERNATIONAL TOWERS LEVEL 24,, 2000 SYDNEY NSW

Description

Kazia Therapeutics Ltd. is an oncology-focused biotechnology company engaged in the development of innovative drugs for cancer. The company's lead program is paxalisib, a small molecule inhibitor of the PI3K/AKT/mTOR pathway designed to cross the blood-brain barrier, which is being investigated for various forms of brain cancer. Its development pipeline also includes EVT801, a selective VEGFR3 inhibitor being studied for its potential to block the growth of blood and lymphatic vessels that support tumor growth. The company focuses on addressing cancers with high unmet medical needs through its portfolio of targeted therapies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-23 18:27
424B3
English 208.7 KB
2025-12-23 18:27
424B3
English 173.3 KB
2025-12-23 17:06
424B3
English 153.5 KB
2025-12-23 17:06
424B3
English 177.3 KB
2025-12-23 01:15 English 5.3 KB
2025-12-23 01:15 English 5.3 KB
2025-12-19 22:46
POS AM
English 203.6 KB
2025-12-19 22:46
POS AM
English 179.9 KB
2025-12-19 22:45
F-1/A
English 198.5 KB
2025-12-19 22:44
F-1
English 444.6 KB
2025-12-19 22:01
6-K
English 8.9 KB
2025-12-18 20:21 English 9.4 KB
2025-12-10 22:11
6-K
English 19.5 KB
2025-12-05 22:05
6-K
English 12.0 KB
2025-12-02 22:05
6-K
English 192.4 KB

Automate Your Workflow. Get a real-time feed of all KAZIA THERAPEUTICS LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KAZIA THERAPEUTICS LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KAZIA THERAPEUTICS LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Initiator Pharma A/S Logo
Clinical-stage company developing drugs for central and peripheral nervous system needs.
Denmark
INIT
Inmolecule Nanotech, S.A. Logo
Develops nanoparticles from plant compounds for biomedical and personal care products.
Spain
MLINA
Inotiv, Inc. Logo
A CRO providing nonclinical drug development services and research models.
United States of America
NOTV
IntegraGen Logo
Provides genomic services for cancer and rare diseases, translating research to practice.
France
ALINT
Intellia Therapeutics, Inc. Logo
A clinical-stage genome editing company developing therapeutics using CRISPR/Cas9.
United States of America
NTLA
InterDigital, Inc. Logo
An R&D company licensing foundational technologies for mobile, video, and AI.
United States of America
IDCC
IntoCell, Inc. Logo
Develops platform technologies for Antibody-Drug Conjugates (ADCs) for oncology.
South Korea
287840
Inventage Lab Inc. Logo
Biopharmaceutical company developing advanced drug delivery systems.
South Korea
389470
Investeko Spolka Akcyjna Logo
Specializes in environmental protection and sustainable business solutions.
Poland
IVE
IQVIA HOLDINGS INC. Logo
Provider of analytics, tech solutions, and clinical research for life sciences.
United States of America
IQV

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.